Grade My Investments
HomeFree Stock Grades › LMRI

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Grade

LMRI · Healthcare

A-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.3B
P/E Ratio
Revenue Growth (YoY)
+7.8%
Net Margin
-4.6%
Return on Equity
Dividend Yield
None

About Lumexa Imaging Holdings, Inc. Common Stock's fundamentals

Lumexa Imaging Holdings is a medical devices company with a market capitalization of $1.3 billion that generated 7.8% year-over-year revenue growth in its latest period. However, the company operates at a net loss with a negative net margin of -4.6%, meaning it is currently spending more than it generates in revenue. The company does not pay a dividend to shareholders, and profitability metrics like P/E ratio and return on equity are not applicable given the net loss position.

Track LMRI free — no credit card required. Live grade + monthly AI report →